Identification of DNA-cisplatin adducts in a blind trial of in situ scanning tunneling microscopy

15Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Scanning tunneling microscopy (STM) reveals nanometer scale details of hydrated DNA but the interpretation of the images is controversial because of substrate artifacts and the lack of a theory for image contrast. We demonstrate that we have overcome these problems by identifying five DNA samples by their STM images alone in a blinded trial. The samples were single-stranded and double-stranded DNA with and without covalent modification by the anti-tumor drug cisplatin. The cisplatin adducts were distinguished by substantial kinking at the drug binding site. The oligomers were 20 bases in length, which was too short to permit the kinking angle to be determined with precision. However, models with a 45° kink gave a better fit to the images of the duplex adducts than models with a 90° kink. A variety of structures was observed for the single-stranded adducts. © 1993 Oxford University Press.

Cite

CITATION STYLE

APA

Jeffrey, A. M., Jing, T. W., Derose, J. A., Vaught, A., Rekesh, D., Lu, F. X., & Lindsay, S. M. (1993). Identification of DNA-cisplatin adducts in a blind trial of in situ scanning tunneling microscopy. Nucleic Acids Research, 21(25), 5896–5900. https://doi.org/10.1093/nar/21.25.5896

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free